sitemapHome | Registration | Job Portal for CA's | Expert Exchange | Currency Converter | Post Matrimonial Ads | Post Property Ads
News shortcuts: From the Courts | News Headlines | VAT (Value Added Tax) | Placements & Empanelment | Various Acts & Rules | Latest Circulars | New Forms | Forex | Auditing | Direct Tax | Customs and Excise | ICAI | Corporate Law | Markets | Students | General | Mergers and Acquisitions | Continuing Prof. Edu. | Budget Extravaganza | Transfer Pricing | GST - Goods and Services Tax
Latest Expert Exchange
« Customs and Excise »
 Central Board of Excise and Customs to be renamed CBIC by April
 Central Board Of Excise & Customs New Delhi GST Flyers
 Hike in customs duty on electronics likely to boost revenue collection
 Customs duty raised on electronic goods
 Ministry Of Finance (Central Board Of Direct Taxes) Notification
 Refund of IGST paid on export of goods under rule 96 of CGST Rules,2017
 Customs And Central Excise Drawback – Part II
 Customs Valuation (Determination of Value of Imported Goods) Rules 2007
 Amendment to Customs Valuation Rules – Notification No. 91/2017 (NT)
 GST on Custom House Agents
 The Customs and Central Excise Duties Drawback Rules, 2017 and All Industry Rates (AIRs) of Drawback related changes

Excise dept moves Supreme Court
April, 15th 2010

The excise department has moved the Supreme Court alleging that antacid Eno Fruit salt is not an ayurvedic medicament as claimed by GlaxoSmithKline Asia Pvt Ltd. It has also sought to recover differential excise duty of more than Rs 9.47 crore towards Cenvat and cess imposed on wrong classification of goods by the pharma major between January 2005 to September 2006.

A Bench headed by Justice SH Kapadia has posted the matter for hearing next week. Challenging the Customs, Excise and Service Tax Appellate Tribunals judgment that ruled in favour of the assessee and two other firms, the department said the product being a medicament and mixture of two or more chemicals packed in unit packs for retail sales fall under heading 3004.

The tribunal had held that Eno Fruit Salt was correctly classified as Patent or Proprietary ayurvedic medicine falling under Chapter Heading 3003.39.

Medicines manufactured exclusively in accordance with the formulae specified in the authenticated books are considered exclusively as ayurvedic medicaments but those which have ingredients of the formulae specified in these books but are manufactured by using the formulation not specified in these text books are considered P or P ayurvedic medicaments.

Southern Drugs Pharmaceuticals (SDP) had entered into an agreement with GSK for manufacture of the antacid.

However, after the introduction of eight-digit code by the Central Excise Tariff (Amendment) Act 2004, SDP had reclassified the product and cleared goods on payment of duty based on the value arrived at on cost construction method since March 2005.

While making its argument, the Revenue stated that the product is sold in the UK, Canada and the US under brand name ENO as a formulated product, that is neither herbal nor ayurvedic nor processed from natural sources.

Home | About Us | Terms and Conditions | Contact Us
Copyright 2018 CAinINDIA All Right Reserved.
Designed and Developed by Binarysoft Technologies Pvt. Ltd.
Binarysoft Technologies - Our Mission

Transfer Pricing | International Taxation | Business Consulting | Corporate Compliance and Consulting | Assurance and Risk Advisory | Indirect Taxes | Direct Taxes | Transaction Advisory | Regular Compliance and Reporting | Tax Assessments | International Taxation Advisory | Capital Structuring | Withholding tax advisory | Expatriate Tax Reporting | Litigation | Badges | Club Badges | Seals | Military Insignias | Emblems | Family Crest | Software Development India | Software Development Company | SEO Company | Web Application Development | MLM Software | MLM Solutions